Zimmer set for its worst day ever after cutting 2025 organic sales growth forecast

Shares of medical device maker Zimmer Biomet Holdings ZBH.N fall 16.1% to $86.49, its lowest in over five years

Stock set for its biggest one day pct. drop ever, if losses hold

ZBH lowers upper end of organic sales growth forecast to 4.0% from 4.5%, maintaining lower end at 3.5%

Co reports Q3 adj.profit of $1.90/shr vs analysts' average estimate of $1.87/shr - LSEG data

Co reports quarterly revenue of $2 billion vs analysts' average expectation of $2.01 billion

ZBH reports 5% organic sales growth in the third quarter

Baird analyst says ZBH failed to "come close to touching" earlier 6% forecast

Including session's move, stock down ~18% YTD